Dark Horse Consulting Group Inc.
Ronald Park is a seasoned executive with extensive experience in the biotech and healthcare sectors. Currently serving as Board Director at Dark Horse Consulting Group Inc. since October 2020, Park has previously held significant roles including Entrepreneur in Residence at Third Rock Ventures and CEO, President, and Board Director at Ambys Medicines. Notably, Park launched innovative health products at Ancestry and led personalized healthcare initiatives at Roche. Early in the career, Park excelled at Genentech and McKinsey & Company, focusing on marketing strategies and business management in the life sciences. Academic credentials include an MD from Stanford University School of Medicine, an MBA from Stanford University Graduate School of Business, and a BA in Biology from Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Dark Horse Consulting Group Inc.
AT DARK HORSE CONSULTING, we work to accelerate cell and gene therapies through our unmatched expertise. Our consulting team has extensive CGT industry experience with knowledge spanning manufacturing, process development, comparability, analytical dev, quant modeling, quality systems, regulatory support, preclinical dev, device dev, program management, facility design and enginnering, market research, and due diligence and business strategy. Many of our consultants also bring experience from adjacent, more mature, sectors, including traditional biologics, small molecules, medical devices, and management consulting. Client requests range from scientific expertise to tactical needs to strategic considerations to business development. We understand the unique challenges faced by Cell and Gene Therapy developers like none other. We apply best practices from across this and other industries to address the needs of our clients, who range from biopharmaceutical companies to tools & tech providers to investment firms.